Stephen C Rodriguez

Summary

Affiliation: Johnson and Johnson Pharmaceutical Research and Development
Country: USA

Publications

  1. pmc Assessment of effectiveness measures in patients with schizophrenia initiated on risperidone long-acting therapy: the SOURCE study results
    Wayne Macfadden
    Ortho McNeil Janssen Scientific Affairs, LLC, Titusville, NJ, USA
    BMC Psychiatry 11:167. 2011
  2. pmc Effectiveness of injectable risperidone long-acting therapy for schizophrenia: data from the US, Spain, Australia, and Belgium
    Tim Lambert
    Ortho McNeil Janssen Scientific Affairs, LLC, Titusville, NJ, USA
    Ann Gen Psychiatry 10:10. 2011

Detail Information

Publications2

  1. pmc Assessment of effectiveness measures in patients with schizophrenia initiated on risperidone long-acting therapy: the SOURCE study results
    Wayne Macfadden
    Ortho McNeil Janssen Scientific Affairs, LLC, Titusville, NJ, USA
    BMC Psychiatry 11:167. 2011
    ..To evaluate effectiveness outcomes in a real-world setting in patients with schizophrenia initiating risperidone long-acting therapy (RLAT)...
  2. pmc Effectiveness of injectable risperidone long-acting therapy for schizophrenia: data from the US, Spain, Australia, and Belgium
    Tim Lambert
    Ortho McNeil Janssen Scientific Affairs, LLC, Titusville, NJ, USA
    Ann Gen Psychiatry 10:10. 2011
    ..abstract:..